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INTRODUCTION 
  
INTRODUCTION 
 
 Carcinoma of the cervix is the commonest type of Malignancy of 
female genital tract in India (Devi and Prabhavathy (1961). 
 
 By virtue of its accessibility carcinoma of the cervix can be readily 
diagnosed even in it's preinvasive stage. If it is treated in early stages, the 
patient can be cured of the disease. 
 
 For each cancer of the body of the uterus, there are 25 cases of 
cancer of cervix in India (Roy Chowdhury, 1975). 
 
 A close quarter observation on the social behaviour of our society 
reveals that more of the women have their marriage at very early part of their 
life leading to early age at first intercourse and poor sexual hygiene which 
are considered to be important etiological factors for the carcinoma cervix. 
 
 The misery of woman due to cervical cancer, which is the commonest 
cancer in a developing country like ours is a scourge of humanity. Early 
detection and management of squamous intra epithelial lesions (SIL) is the 
best approach to achieve control over cancer cervix. Cytological screening 
by pap smear has brought down the incidence of cervical cancer in 
developed countries. Better information can be provided by a molecular 
tumour marker. One such molecular tumour marker is AgNOR, which stands 
for silver stained (Ag) nucleolar organizer regions (NORs). 
  
  
Nucleolar organizer regions (NORs) are loop of ribosomal DNA 
located in the short arms of acrocentric chromosomes 13,14,15, 21 and 22 
and transcribe to ribosomal RNA. NORs vary in size and shape according to 
nucleolar transcription. They are intimately related to cell cycle and may be 
related to proliferation and ploidy. 
 
 AgNORs are argyrophilic proteins. Binding of silver and protein occurs 
in carboxyl and sulphydryl groups by colloidal precipitation of ionic silver. 
The carboxyl groups on the protein reduces the silver solution forming micro 
nuclei of silver. The large aggregates of silver are deposited at disulphide 
and sulphydryl group sites. These are seen by light microscopy as black 
intranuclear granules. 
 
 AgNOR count is an important index for assessment of proliferation of 
cells. In normal cells, the AgNORs are tightly packed in the nucleoli and are 
discernible. In rapidly proliferating cells such as neoplastic cells, nucleolar 
disaggregation may take place resulting in dispersion of individual AgNOR. 
Recent studies show that AgNOR are significantly more in malignant cells 
than in normal cells. 
 
 In a normal cell, 20 black dots of AgNORs should be seen (2 per arm 
of chromosome i.e. 2 x 10 = 20) but only one or two dots are seen as the 
dots are tightly packed. As we move from normal cells towards the dysplastic 
cells and malignant cells, the amount of DNA increases, and the number of 
AgNOR dots (AgNOR Count) also increases. It reflects current phase of 
transcription.  
  
The AgNOR technique provides an index of cell proliferation. The 
number, shape and distribution of AgNOR dots counted in the cell gives 
information not only about the morphology but also about the behaviour of 
the cell. It is useful in differentiating doubtful cases of CIN. 
 
AgNOR counts also has prognostic significance. CIN lesions with low 
AgNOR counts are more likely to regress in comparison to CIN lesions with 
high AgNOR counts. It is a simple, efficient and inexpensive method, which 
can be used as an adjunct to routine cytology and histopathology for 
diagnosis of cervical lesions especially in doubtful cases. 
 
In the present study AgNOR counts of cervical lesions is compared 
with those of HPE. The results are analysed for statistically significant 
difference in different groups. 
 
  
 
 
 
 
 
AIM OF THE STUDY 
  
AIM OF THE STUDY 
 
1. To screen women with abnormal symptoms by speculum 
examination. 
 
2. To take punch biopsy of abnormal cervix for histopathological analysis 
with H&E stain and AgNOR scoring with silver stain. 
 
3. To correlate AgNOR counts of cervical lesions with histopathology. 
 
 
  
 
 
 
 
 
REVIEW OF LITERATURE 
  
REVIEW OF LITERATURE 
 
 Cell kinetics plays an important role in tumour behaviour. Proliferation 
rates of the tumour can be assessed to determine the behaviour of a 
particular tumour. The cell cycle can be divided into four phases based on 
the nuclear chromatin activity (Diag – 1). They are S, G1, G2 and G0 phases. 
The cells show active reduplication of DNA in the S phase. There is a short 
resting phase of the cell undergoing replication at the 'S' phase. G2 is the 
second resting phase before active mitosis. Thus, the DNA content at the 
end of 'S' phase is an indicator of proliferative activity. AgNOR detects the 
DNA content at this stage. 
 
 Stable cells are quiescent cells in G0 phase and can be stimulated 
into G1 by an appropriate stimulus. The tumour suppressor gene P53 blocks 
the progression of cells through the cell cycle late in the G1 phase of 
replication. Mutant forms do not have this effect. 
 
 During the phase of active DNA replication, strips of DNA containing 
RNA genes are seen inside the nucleolus. These DNA fragments are 
actively transcribing with the help of polymerase I enzyme. These are 
considered as ribosomal factories. Cell cycle is controlled by a few enzymes 
called M phase promoting factors. 
 
 This factor has two subunit proteins. 
1. 34 Kd protein, which is the product of the Cdc2 gene. 
2. 45 Kd subunit consisting of proteins, which accumulate during 
cell cycle and are destroyed by the end of mitosis. 
  
These proteins are named as "cyclins". The inactivation of these 
cyclins, inactivates M phase promoting factors also and so, this protein is 
required to end mitosis in a cell cycle. 
 
Other important molecular events i.e. phosphorylation and 
dephosphorylation are needed to control various cellular events in mitosis 
and interphase. Many substrates have been identified for the P34 kinase and 
other cyclins, histones (in nuclear envelope breakdown), PP60 and nucleolin. 
Nucleolin is a major argyrophilic protein controlling the entry of cells into 
mitosis. Other nuclear proteins incorporated in the argyrophilic reaction are 
RNA polymerase I enzyme (important in transcription) no. 28/B23 protein as 
found by Jordan G47 (1987). 
 
According to Belerguer P et.al (1996) nucleolin plays an important 
role in DNA transcription. It is responsible for the entry of cells into mitosis. It 
is the major substrate for the 34cdc2 kinase system, which controls the cell 
entry into the premitotic and mitotic phase. It controls the RNA splicing 
through its action on rDNA and the formation and assembly of ribosomes. 
P34 cdc2 phosphorylates the nucleolin and thus causes major 
conformational changes in the DNA and this results in transcription and 
hence the argyrophilia of nucleolin as found by Peter M (1990). 
 
Underwood and Giri (1988) found that No.28/B23 functions in the 
intranuclear assembly of periribosomal particles. Thus these NORs visualize 
the ribosomal gene activity and hence functional protein demand of the cell. 
This increased protein demand and thus the proliferative rate of these cells 
is indicated by silver staining. NORs exist in constant positions on short arm 
  
of acrocentric chromosomes namely 13,14,15,21 and 22. These are clearly 
demonstrated at metaphase. Twenty NORS could be demonstrated at this 
phase. This is because NORs occur in pairs on the acrocentric 
chromosomes. 
 
The precise localization of NOR, has been found to be in the 18S 
rDNA gene cluster in the stalk region. However, exceptions do occur. 
 
An increase in the number of AgNORs counted in any given section 
could be explained as follows. 
a. Increase in the number of AgNOR bearing chromosomes in 
the karyotype. 
b. Increase in transcriptional activity producing more visible 
argyrophilic cells. 
c. Increase in the proliferating rate of cells resulting in large 
population showing positivity. 
d. Tumours with increased AgNOR counts in interphase nuclei 
are more likely attributable to cellular proliferation than to N 
ploidy, because diploid cells are tetraploid in G2 phase 
transiently, resulting in temporary doubling of NOR bearing 
acrocentric chromosomes as found by Crocker et al (1989). 
Immediately before and after mitotic division, the NORs 
disperse and then re-aggregate leading to increase in the 
number of countable AgNORs in the nuclei. 
 
 
 
  
Ultra structural appearance of Mammalian Nucleoli (Diag – 2) 
a. Granular component : It is composed of distinct spherical shaped 
granules each about 15 nm in diameter. 
b. Dense fibrillar component : It is consisting of tightly packed electron 
dense 3-5 nm thick fibrils. 
c. Fibrillar centre : It is consisting of a loose network of fibrils with a 
little greater average diameter (4-8 nm) than the dense fibrillar 
component. 
 
Crocker et al (1989), derived procedures of importance followed 
internationally, for a simple single step colloidal silver staining technique. 
 
The fibrillar centre seen in electron microscopy is the equivalent of the 
interphase AgNOR seen at the light microscopy level. 
 
History of AgNOR 
 AgNOR are loops of DNA that encodes for ribosomal RNA production 
by polymerase I. NOR are argyrophilic, hence detected by silver 
impregnation technique. Number of AgNORs in a cell nucleus reflects the 
cell kinetics and proliferative activity. 
 
 In rapidly proliferating cells like neoplastic cells, nucleolar 
disaggregation may take place resulting in dispersion of individual AgNORs. 
 
AgNOR in the field of oncology 
 Study of AgNORs has started gaining importance in the field of 
oncology. Dr. J. Crocker and M.J. Egan (1988) in their study of AgNORs in 
  
36 lymphoma cases demonstrated that in non hodgkin's lymphoma, 
AgNORs diminish in size and increase in number from low grade to high 
grade malignancy. They may represent elevated transcription leading to 
more r RNP gene copies with increasing malignancy. 
 
 In 1993 Dr. Derenzini D'Trere identified that high number of 
metaphasic AgNORs in hepatocytes of patients with chronic liver disease is 
associated with increased risk of hepato cellular carcinoma. 
 
 Yamanoto N (1993) studied the NOR proteins in renal cell carcinoma 
and it's significance as a marker of proliferative activity. The increase in 
Argyrophilic nucleolar protein of a cell has been shown to reflect the rDNA 
transcriptional activity and state of cellular activity. The AgNOR values in 
renal cell carcinomas were higher than those in the normal tubules and the 
numbers increased with the progress of grades. Moreover, the numbers of 
NOR, were higher in infiltrating types such as Sarcomatoid type. The 
patients with renal cell carcinoma having counts of 4.5 or more showed a 
significantly poor prognosis. 
 
 Isaka et al (1993) examined AgNORs in 96 patients with renal cell 
carcinomas and concluded that the number of AgNORs increased along with 
upgrading. When AgNORs were compared in various cell types, the number 
in pleomorphic, spindle cell and Bellini duct carcinoma were more than that 
in common types. 
 
 Shimazui T et al (1995) evaluated the prognostic significance of 
nucleolar organizing regions in renal cell carcinomas and found that the 
  
NOR indices correlated well with survival curve. The low NOR index group 
had a survival rate of 100% while in those patients with higher NOR index 
the mortality was significantly increased. The patients with a low NOR index 
have a better prognosis than those with a high NOR index within each 
tumour grade. 
 
 V.V. Radhakrishnan and D.Rout (1994) selected 10 cases of 
Medulloblastoma in which there are difficulties in making histopathological 
diagnosis as cells of internal granular layer of cerebellum resembled cells of 
medulloblastoma. By AgNOR there was an average of AgNOR count 0-
2/nucleus in cells of internal granular layer and an average of 4.82 AgNORs 
per nucleus of medulloblastoma cells. 
 
 Tannafel A et al (1996) studied the prognostic value of ploidy and 
proliferation markers in renal cell carcinomas and concluded that cellular 
proliferation may prove to be another method of predicting biologic 
aggressiveness. Statistical correlation were seen between tumour grade and 
AgNOR dots. 
 
 Tomobe N et al (1997) stated that AgNOR is a new prognostic 
indicator for patients with renal cell carcinoma. 
 
 Delahuni B et al (1988) assessed the prognostic markers for renal cell 
carcinoma and evidenced that only nuclear grade was associated with the 
outcome out of all other prognostic parameters tested in various studies. 
Only assessment of tumour proliferation markers (Silver staining nucleolar 
  
organiser regions, PCNA and Ki-67antigen) had shown consistent 
association with survival. 
 Smith R, Crocker J, in 1988, studied the significance of NOR in breast 
malignancy, and proved its statistical significance. 
 
 In 1989, Giri, DD Nottingham JF, Lowry J et al, correlated AgNOR, in 
benign and malignant breast lesions. 
 
 In 1988, J. Crocker and Paramjithnar from Department of 
Histopathology, East Birmingham Hospital studied AgNORs in 90 paraffin 
sections of non hodgkin's lymphomas. A significant difference was found 
between the number of AgNORs in the nuclei of low grade lymphomas (from 
the mean of 1 to 1.5 / nucleus) and those of high grade lymphomas ( a mean 
of 4.4-6.8 per nucleus). 
 
AgNOR in Gynaecological Oncology 
 John Crocker, David, A.R. Boldy and Mark et al in 1988 enumerated 
standardized approach in counting AgNOR. 
 
 Firstly all Silver stained structures could be counted but when lying in 
groups, each cluster (almost aggregated or partly disaggregated nucleoli) 
treated as one structure. 
 
 Secondly where AgNOR could be counted within a nucleolus each 
AgNOR could be counted as 1 unit together with the smaller AgNOR seen 
outside the nucleus. Overall he suggested that total AgNOR dots both intra 
and extra nucleolar be enumerated. 
  
 
 In 1995, D. Prathiba, Sarah Kuruvilla et al of Sri Ramachandra 
Medical College and Research Centre, Chennai studied the value of 
AgNORs in premalignant and malignant lesions of the cervix. The mean 
AgNOR count was found to increase progressively from normal to CIN I, II, 
III and invasive carcinoma. 
 
 In 1989, Newbotd M, Rollason P, Ward K studied the NOR and 
proliferative index in glandular and squamous carcinomas of the cervix and 
found that they have pattern with complete loss of polarity with Significant 
Prognostic Value – J. Clin. Patho 1989; 42 : 441-2 
 
 In 1993, Lakshmi S, Nair SA, Jayashree R et al studied the AgNOR in 
inflammatory, premalignant and malignant lesions of the cervix and showed 
gradual increase in NOR count with increasing severity of dysplasia.             
- Cancer Lett 1993; 71 : 197-201. 
 
 In 1997, Agarwal J, Gupta JK studied the difference in NOR's in 
neoplastic and non neoplastic epithelium of the cervix. - Ind J. patho; 
1997;40;125-7. 
 
 In 1997, March Calore EE, Made My. Cavaliere MJ of Brasil 
conducted a study of AgNOR technique in cervical intra epithelial neoplasms 
and found that AgNOR counting can be useful in the identification and 
classification of individual cases of intra epithelial neoplasia and their 
differentiation from difficult cases of cervicitis. - Minerva Gynecol 1997, 
March 493, 59 to 62. 
  
 
 In 1997, Jyotima agarwal, J.K. Gupta et al of Department of 
pathology, Kamala Nehru Memorial Hospital, Allahabad found that Mean 
AgNOR count in CIN and Malignant metaplasia and chronic cervicitis and 
also adeno carcinomas have higher AgNOR when compared to squamous 
and adeno squamous carcinoma. - Indian J Pathol and Micro 40 (2) 125-127 
(1997). 
 
 In 1998 May, Terlikowski S, Lehezewski A, Sulkowski S, Sulkowski M, 
compared AgNOR counts of CIN II and SIL and suggested that AgNOR 
counts could be of significance in the evaluation of cervical lesions and could 
elaborate histopathological diagnosis. 
 
 In 2001, J.S. Misra Vinita Das and Madhulika Singh et al of 
department of O & G King George's Medical University Lucknow, India 
performed an assessment of AgNOR count as tumour marker in cervical 
carcinogenesis. It showed importance of AgNOR in discriminating cervical 
lesions, high AgNOR in follow up study with progression to dysplastic lesion. 
 
 In 1999, Kurian, Al Nafussi et al studied the relation between cervical 
glandular intra epithelial neoplasia to micro invasive and invasive adeno 
carcinoma of cervix. - J. Clin. Pathol. 1999, 112, 117. 
 
 In 2001, Sakai Y, Sakai AT, Isotani S, Caveliere MJ, De Almeid et al 
of Adoifo latry institute Pathology division Saopauls had done morphometric 
evaluation of NOR of intra epithelial neoplasia. They found that number of 
cells with one dot decreased with increasing grade of CIN. Number of cells 
  
with more dots increased with increasing grades of CIN. Total number of 
dots per 100 cells increased with increasing CIN and concluded that 
counting the cells with 4 or more dots is the parameter for distinguishing the 
grade of CIN. - Pathol. Respract 2001, 1997 (3) 189-192. 
. 
 In 2003, Rajini Kawshik, Vijaysharma, Archana Gulate RR Sharma et 
al of Department of Pathology ICMC Shimla studied AgNOR counts in 
cervical lesions. They found that AgNOR as a reliable indicator of cell 
proliferation and malignant potential of the lesion and can be used as an 
adjunct in routine histopathology in the cervical lesion. - Indian J. Pathol & 
Micro 2003, Vol. 46, No (2) 2001-2003. 
 
 In 1998, Rowlands DC studied AgNOR in cervical intra epithelial 
neoplasia and proved the increase in count as the dysplasia progresses.       
-J.Clin. pathol. 1998 41; 1200-2. 
 
 In 1989, Cullimore JE, Rollason TP, Marshall T studied AgNOR in 
adenocarcinoma insitu of endocervix and proved the prognostic value.          
- J. Pathol. 1989; 42: 1276-80. 
 
 Egan M, Freeth M, Crocker J studied the relationship between intra 
epithelial neoplasia of cervix and the size and number of AgNOR dots, size 
and number increased in advanced grades of intra epithelial neoplasia.         
- Gyn. Onc. 1990, 36; 30-33. 
 
 Kafil Akhtar, Ghazala Mehdi, Veena Maheswari, Shahid Ali Siddiqui : 
Rajyashri Sharma from Department of Pathology, Radio therapy and 
  
gynaecology, J.N. Medical College, Aligarh Muslim University, Aligarh. 
conducted a study on diagnostic and prognostic significance of AgNOR 
counts in radiotherapy treated squamous cell carcinoma of the cervix and 
concluded that AgNOR is an effective tool, reflecting the proliferation rate of 
tumour and has a significant diagnostic and prognostic value in tumour 
pathology. - J. Obstet Gynaecol India W155, No. 2, Pg 163-166. March –
April 2005. 
 
 The major advantages of AgNOR staining technique 
1. Cost and time effectiveness. 
2. It can be used on archival as well as fresh tumour material. 
3. It can also be observed on smear squash cytologies and all 
cultures. 
4. It does not require special fixatives or complex apparatus. 
 
The major disadvantages are 
1. The counting procedures adopted are usually manual and 
hence long and tedious. 
2. Observer error is the major cause of inaccuracy and 
inconsistency. 
3. The dots of AgNOR interphase nuclei need not always 
correspond actively to the number of such types in the 
karyotype, as found by Underwood and Giri 98. (Loc cit. 
1988) 
4. Overlap and coalescence may result in misjudged counts 
as said by Crocker et al. 22 (Loc cit 1989). 
 
  
CIN 
 
 The epidemiological data correlate well with the current understanding 
of the pathogenesis of cervical neoplasia. The incidence of cervical 
dysplasia is reported to be 15 : 1000 in women who were cytologically 
screened. The incidence of severe dysplasia is reported to be 5 : 1000 
according to ICMR studies (Shaw). 
 
 The period of early squamous metaplasia is the time of greatest risk 
for cellular transformation and development of cervical neoplasia. In this 
period young metaplastic cells have phagocytic properties and if some 
potent mutagen is present in the vagina during this time, the epithelium 
might undergo the cellular transformation. The early squamous metaplasia 
occurs almost exclusively in puberty and early adolescence and in the first 
pregnancy. Therefore women who begin sexual activity at an earlier age 
when the metaplastic process is more active, have a greater chance of 
developing cervical carcinoma. 
 
 Age adjusted incidence rates for invasive cancer ranges from 19-
44/100,000 women in various cancer registries in India. Higher incidence is 
noted in Chennai 43.5/1,00,000 followed by 30.1/100,000 at Delhi and 
19.4/100,000 at Mumbai. 
 
 The cumulative risk of CA cervix is 1.58% in Mumbai and 3.6% in 
Chennai. In other words, 1 in 62 woman in Mumbai and 1 in 28 woman in 
Chennai may develop cancer cervix in their life (ICMR – 1992). 
 
  
Natural History of CIN 
 Original squamous epithelium is derived from the congenital sinus 
epithelium, starts at the vulvovaginal line, lines the vagina, covers the major 
portion of the cervix and abuts upon the columnar epithelium to form the 
original squamocolumnar junction. 
 
 Under low vaginal acidity, the reserve cells proliferate, lifting the 
columnar epithelium. There is centripetal growth of original squamous 
epithelium growing beneath the columnar epithelial cells. Process of   
squamous metaplasia begins in the lips of the columnar villi which are first 
exposed to vaginal acidity. 
 
 A new squamocolumnar junction is continuously formed that gradually 
replaces the native columnar epithelium. The deeper clefts, however, may 
not be completely replaced by the metaplastic epithelium, trapped under the 
squamous epithelium resulting in the formation of Nabothian cysts. Gland 
openings and nabothian cysts mark the original squamocolumnar junction 
and the outer edge of the original transformation zone. The area between 
original squamocolumnar junction and the new squamocolumnar junction is 
referred to as Transformation Zone (TZ). 
 
 Physiologic transition occur during 3 phases of life. 
1. Foetal 
2. Menarche 
3. First Pregnancy 
 
 
  
Anatomy of Transformation Zone 
 Proximal border of transformation zone is the upper limit of squamous 
metaplasia where the immature squamous metaplasia abuts a 
circumferential ring of unaltered columnar epithelium. 
 
Original Squamocolumnar junction has 4 layers. 
1. Basal layer : Single row of immature cells, with large nuclei and small 
cytoplasm. 
2. Parabasal layer : Two to four rows of cells that have normal mitotic 
figures. 
3. Intermediate layer : Includes four to six rows of cells with large 
amount of cytoplasm in a polyhedral shape separated by intercellular 
space. 
4. Superficial layer : Includes five to eight rows of cells with small 
uniform pyknotic nuclei and acidophilic cytoplasm filled with glycogen. 
These cells exfoliate and form the basis for pap smear. 
 
Columnar Epithelium 
 Single layer of columnar cells with mucus at the top and a round 
nucleus at the base. 
 
Metaplastic epithelium 
 Transformation from columnar epithelium to squamous epithelium is 
known as metaplasia to the histologists and as TZ to the colposcopists. This 
is the area of development of neoplasia and the area of interest to the 
colposcopists. It's caudal limit is the original squamocolumnar junction and 
cephalic limit is the new squamocolumnar junction. 
  
Pathogenesis of CIN 
 In most cases, CIN is believed to originate as a single focus in the 
transformation zone at the advancing SCJ. The anterior lip of cervix is twice 
as likely to develop CIN as the posterior lip and CIN rarely originates in the 
lateral wall. 
 
 Once CIN occurs, it can progress horizontally to involve the entire TZ, 
but usually does not replace the original squamous epithelium. Proximally 
CIN involves the cervical clefts and the area tends to have more severe 
lesions. 
 
 CIN is most likely to begin either during menarche or after first 
pregnancy, when metaplasia is more active. Conversely, a women who has 
reached menopause without developing CIN has little metaplasia and is at a 
lower risk. 
 
Progression and Regression of CIN 
 The spontaneous regression rate of biopsy proven CIN I is 60-85% in 
prospective studies. This regression typically occurs within a 2 year follow up 
with cytology and colposcopy.. 
 
 This information has led to the recommendation that patients who 
have biopsy diagnosis of CIN I with satisfactory colposcopy and who agree 
to the evaluation every 6 months can be treated by observation. If the lesion 
progresses in follow up or persistent after 2 years, ablation is recommended. 
(Novak's gynaecology) 
 
  
Etiology and Risk factors 
 
1. Marriage and sexual behaviour 
 Increased risks are associated with coitus at an early age, coitus with 
multiple sex partners, and coitus with high risk men (Miller et al 1976, 
Canadian Task Force – 1982). 
 
2. Local hygiene 
 Cancer cervix is found to be positively associated with lack of daily 
genital washing and negatively with the use of clean sanitary napkins during 
menstruation (Zhang et al, 1989). 
 
3. Contraception 
 Barrier methods may be protective while OCP increases the risk of 
CIN and invasive cancer which is attributed to the hormonal changes 
produced in the cervical epithelium (Beral et al, 1988). 
 
4. Dietary Factors 
 Deficiency of Vit A, C, E and folic acid are related to cancer cervix and 
dietary supplementation of these vitamins may prevent its occurrence 
(Verreault , 1989). 
 
5. Smoking and Douching 
 Smoking and  douching with tar substance may have a role in CIN 
(Winkelstein  et al, 1991). Smoking more than 10 cigarettes per day had 
increased the relative risk to get CIN and invasive cancer. (Nunez et al, 
2002). 
  
6. STD 
 There is a definitive association of Human Papilloma virus (HPV) – 
16, 18, 31, 33 with CIN. HPV – 16 is associated with CIN. HPV – 18 is 
associated with high grade squamous cell carcinoma and HPV – 18 is 
associated with adenocarcinoma , HPV – 31,33,35 are associated with 
intermediate oncogenicity (Crum et al, 1985, Levine et al, 1984). Increased 
risk of cervical cancer has been reported with other STD infections like HSV 
– 2, HIV and CMV. This risk is found to increase significantly with increase in 
the  number  of apparent organisms. (Schmauz et al, 1989) 
 
7. Immunosuppression 
 Both preinvasive and invasive lesions are more prevalent in 
chronically immuno compromised women, eg. In HIV (Maimen et al – 1998) 
and in renal transplants (Alhoub et al – 1988 and Mayernon et al – 1991). 
 
8. Parity 
 Although multiparity is associated with increased incidence of 
carcinoma cervix, there is no significant evidence to prove it. (Cramer et al, 
1986) 
 
Dietary factors HPV Types – 16,18,31,33  Altered Immune status 
*Deficiency of  HSV – 2    * HIV 
Vit. A and folic HIV, CMV    * Renal transplants 
Acid 
 
 
CIN 
 
Early age at first coitus       Multiple sex partners 
 
 
Poor personal hygiene  Smoking  OCP 
Low socio economic status 
  
 The transformation to premalignant changes is a rapid process that 
lasts for days or weeks at the most, but the promotion of these changes is a 
long term process. Some lesions can stay on the cervix indefinitely without 
change and some can progress quickly to CIN or invasive carcinoma 
depending on host response. 
 
Scheme of pathogenesis of cervical neoplasia from STAFLA, 
MATTINGLY RF. AMJ. O.G. 1977 
Columnar epithelium 
Low pH of vagina 
 
Early metaplasia 
 
Physiological metaplasia    Atypical metaplasia 
 
 
Normal Transformation zone   Abnormal Transformation  
Zone 
 
 
Well differentiated squamous  Adequate host Inadequate 
epithelium      response   host response 
 
 
      No progression Dysplasia 
 
 
                 CIN 
 
 
             Invasive carcinoma 
  
 CIN I and CIN II require treatment. This is based on metaanalysis 
showing that CIN II progresses to CIS in 20% of cases and to invasion in 
5%. 
CIN Regress. Persist Progress to 
CIN III 
Progress to 
invasive CA 
CIN I 57% 32% 11% 1% 
CIN II 43% 35% 22% 5% 
CIN III 32% 56%  >12% 
 
(From Ostor AG-Inter. J. Gynaecol. Pathology, 1993; 12) 
 
Precursors of invasive squamous cell carcinoma 
 The term dysplasia was first introduced by Reagan in 1953. Dysplasia 
represents a change causing an alteration and disorderly arrangement of the 
differentiated basal cells of stratified squamous epithelium. 
 
 The three degrees of dysplasias mild, moderate and severe  
according to Novak and Woodruff (1979) are characterised by, 
 
i) Mild  
The dysplastic cells extend from one quarter to one third of the way 
from the basal layer. 
 
ii)  Moderate 
Cellular aberrations extend through one half to two third of the 
thickness of epithelial layer. 
 
iii)  Severe 
 The dysplastic cells penetrate through 75-90% of the epithelium. 
  
 Histopathology appearance of severe dysplasia resembles carcinoma 
in situ with the exception that a few cell layers near the surface are still 
capable of maturation. 
 
 Carcinoma in situ is characterized by malignant change involving the 
whole thickness of the squamous epithelium from the basement membrane 
to the surface, disclosing an immature disorganized pattern with complete 
loss of polarity. 
 
 Richart (1966) first introduced the term cervical intra epithelial 
neoplasia (CIN) to denote the ranging degrees of intra epithelial 
abnormalities. The varying degrees of CIN ranging from mild dysplasia to 
Carcinoma in situ represents a continuum in the neoplastic process. 
 
 Richart (1966) graded the various degrees of CIN into 
 CIN I – Mild dysplasia 
 CIN II – Moderate dysplasia 
 CIN III – Severe dysplasia and Carcinoma in situ 
 
Carcinoma in situ has been grouped under CIN, although 
histologically there is a slight difference between severe dysplasia and 
carcinoma in situ. 
 
Therepeutically and prognostically there is hardly any difference 
between the two. 
Feature variations with increasing severity of dysplasia 
Decrease Increase Varies 
Cellular cohesion 
Amount of cytoplasm 
Multinucleation 
Degree of maturation 
Normal flora 
Mitosis 
Nuclear cytoplasmic ratio 
Anisochromatism 
Nuclear membrane irregularities. 
Nuclear hypertrophy 
Anisokaryosis 
Hyperchromatism 
Nucleoli 
  
Screening Procedures for CIN 
  
1. Pap Smear 
2. Colposcopy 
3. Cervicography 
4. Speculoscopy (VIA, VILI) 
5. HPV DNA detection and typing 
6. Polarprobe (Truscan) 
7. Spectroscopy 
 
Pap Smear 
 The pap smear initially described by papanicolaou and Traut is used 
to detect exfoliative cells from the cervix that may be precancerous or 
cancerous. 
 
Conventional Pap Smear 
 According to American Cancer Society, ideal time to take pap smear 
is 5 days after menstruation. The patient should be instructed not to use a 
vaginal douche or any type of lubricant or spermicide for 24 hours prior to 
having a cytologic specimen obtained. The ectocervix and the area of vagina 
adjacent to the cervix must be fully visible when smear is obtained. The 
patient should not bleed and should not have marked vaginal infection. The 
infection must be treated accordingly and patient must be rescheduled for 
pap smear during next cycle. 
 
 The smear is taken with Ayer’s spatula or with moistened brush 
around the external os by making 3600 rotation with minimal pressure and 
  
smeared and fixed in a glass slide with 95% alcohol. Staining done with 
papanicolaou staining procedure which employ, 
 Haemotoxylin as a nuclear stain and 
 Orange G – 6 and Eosin alcohol (Eo-36) as cytoplasmic 
counterstains. The slides are finally mounted in Canada 
balsam and examined and interpreted. 
 
Various forms of Interpretations 
 
Papanicolaou (1943) Richart WHO (1975) Bethesda 
(1998) 
Gr I – Normal cells Normal Negative for cancer Normal 
Gr II – Slightly abnormal, 
suggestive of inflammatory 
changes. Repeat smear after 
treating infection 
Negative Atypical squamous 
cells 
Inflammatory
- HPV 
- ASCUS 
Gr III – More, Serious type 
usually indicative of biopsy 
CIN I Mild dysplasia Low SIL 
Gr IV – Distinctly abnormal 
and definitely require biopsy 
CIN  II 
CIN III 
Moderate and severe 
dysplasia 
High SIL 
Gr V – SCC SCC SCC SCC 
 
 
Cervical biopsy 
 Gold standard confirmatory test. Different types of biopsy methods 
are done which include punch biopsy, Loop excision biopsy and conisation 
biopsy. Punch biopsy is the most commonly practiced method but it tends to 
crush and may not include stroma. A low voltage diathermy loop biopsy 
  
requires more sophisticated equipment but can control haemorrhage and 
produces samples of greater size. Prendiville et al have shown that the 
artefactual damage is minimal and a larger biopsy can be taken for the 
diagnosis of microinvasion or invasion. 
 
  
Screening Intervals 
ACS – American cancer society 2002 guidelines 
 
1. Age to  initiate screening : Three years after the onset of sexual 
activity, not later than the age 21. 
2. Screening frequency : Annually with conventional cytology or every 
2 years with liquid based cytology. After the age of 30, women with 3 
consequetive normal tests may be screened every 2-3 years. 
3. Screening after hysterectomy : No cytologic testing after total 
hysterectomy for benign conditions. 
4. Discontinuation : After the age 70 
5. Routine screening for HPV infection : Not yet FDA approved. If 
approved, conventional or liquid based cytology combined with test 
for DNA from high risk HPV types should be performed not more often 
than every 3 years. 
 
  
Management of CIN 
 
1. Management of Low grade CIN (CIN I) 
a) Expectant Management :- As 60% of CIN I lesions regress 
spontaneously, observation and prospective follow up of the patient  
who is willing to come for regular  follow up is adequate. The follow 
up is done with any of following methods :- 
a. Cytology 
b. Colposcopy 
c. Cervicography 
d. HPV DNA detection and typing 
 
These patients should have repeat assessments at 4 to 6 monthly 
intervals. The patient can exit the surveillance program once three 
negative cytological smears are obtained. 
 
b) Active management :- It is indicated if  
a. The patient will not adhere to close follow up. 
b. Lesion persists for one year. 
c. Association with high risk HPV is documented. 
d. HIV infected patients. 
e. The patient requests treatment 
 
Ablative techniques for treating CIN 
Prerequisites 
i) The entire lesion is visualised within the TZ. 
ii) There is no suspicion of microinvasive or invasive cancer. 
  
iii) There is no suspicion of endocervical glandular disease. 
iv) The cytology and histology should correspond. 
v) A high degree of clinical expertise 
vi) The patient should be compliant with follow up for atleast three  
years. 
 
Timing – performed in the postmenstrual period under colposcopic 
guidance. 
Types 
1. Cryotherapy – Rapid freezing causes crystallization of cell water 
leading to cell dehydration that causes increase in the concentration 
of intracellular salts and release of lysosomal enzymes which cause 
disruption of cell membranes and organelles. Freeze – thaw – freeze 
technique is used. CO2 at –600c and N2O at –890c are the gases 
used. Depth of tissue destruction is around 4-5 mm. No anaesthesia 
is required. Complications like uterine cramping, profuse watery 
discharge, slight spotting may last for 2-3 weeks. Cure rate is 99%. 
 
2. Electrocoagulation diathermy (Electrodiathermy) – This destroys 
tissue by a combination of fulguration and coagulation. Done under 
general anaesthesia. Temperatures > 700c are produced making this 
procedure painful. Discharge and bleeding may occur postoperatively. 
Depth of tissue destruction is atleast 7 mm and cure rate of 88-97% 
are quoted. 
 
3. Electro coagulation – Here, the tissue is destroyed by the 
application of a thermasound heated to 1200c to the cervical surface. 
  
Treatments of approximately 20 seconds are given to five overlapping 
areas. Local anaesthesia is required and cure rate of 94% may be 
achieved. 
 
4. Laser vaporization – Laser energy boils intracellular water, 
producing steam and exploding the cell. CO2 laser is most commonly 
used. Energy density of 20-25 W, power density of 500-1200 w/cm2 
and a beam spot diameter of 1.5 to 2 mm used. Depth of destruction 
achieved is 6-7 mm and  procedure is completed in 15-20 minutes. 
Advantages are ; depth and extent of tissue destruction can be 
accurately controlled, rapid healing of margins, minimal bleeding and 
discharge and TZ will be visualised during follow up. 
 
Management of high grade CIN (CIN 2 and CIN 3) 
 Exicisonal techniques are preferred. Types of exicisional procedures 
are:- 
1. Conisation – Cold knife conisation 
2. LLETZ – Large loop electro surgical exicision of transformation 
zone 
 
Indications :- 
i) Unsatisfactory colposcopy 
ii) Suspected invasion on cytology, colposcopy or biopsy 
iii) Endocervical curettage is positive 
iv) Lack of correlation between cytology, colposcopy and biopsy 
v) Suspected adenocarcinoma 
  
Types of cones – shallow cones where lesion is visible and columnar 
epithelium is also visible in the cervical canal. 
 
 Deep cones when the apex of lesion is in the cervical canal and part 
of lesion is out of sight. Not performed in woman, desirous of future 
childbearing. 
 
  Cold knife 
conisation 
Laser conisation 
1. Admission and anaesthesia Needed and GA Office procedure 
LA 
2. Colposcope Not used Used 
3. Healing process Slow Rapid 
4. Scarring and Stenosis Present (26-36%) Rare (7%) 
5. Visibility of new SCJ No Yes 
 
 Depth of tissue destruction in laser conisation is 7-8 mm. Efficacy is 
96%. 
 
LLETZ 
Indications 
i) High grade CIN 
ii) CIN I persisting for > 12 months 
iii) Glandular intraepithelial neoplasia 
 
Contraindications  
i) Extremely large lesions 
ii) Vaginal extension 
  
iii) Obvious clinical carcinoma 
It is done under local anaesthesia under colposcopic guidance. The 
loop is advanced into the cervix just lateral to the TZ until the required depth 
has been achieved. It is then slowly taken across the cervix enveloping the 
TZ. Fine wire loops 2.5 x 2.5 cm with electrosurgical units with power output 
of 30 and 60  W units are used. Cure rates for small loops are 80% and for 
large loops are 90%. The specimen is marked at the endocervical canal 
margin at 12 o’clock position with a needle. 
 
The main advantages are; Short time, less morbidity and a tissue 
specimen for pathological examination is available. 
 
Hysterectomy – can be considered for the treatment of CIN in; 
1. Poor compliance for follow up. 
2. Microinvasion. 
3. Positive cone margins. 
4. Associated gynaecological problems like fibroid, prolapse. 
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MATERIALS AND METHODS 
 
 This study was carried out in Department of Obstetrics and 
Gynaecology, Govt. Rajaji Hospital in collaboration with Department of 
Pathology, Madurai Medical College in the period of May 2005 to May 2006. 
 
 50 patients from gynaec outpatient department and gynaec ward were 
randomly selected for this study after obtaining informed written consent. 
Criteria for selecting women for study was the presence of one or more of 
the factors given below. 
 
Inclusion criteria 
1. Age : 20-60 years. 
2. Patients with abnormal symptoms like profuse white discharge, post 
coital bleeding, intermenstrual bleeding or post menopausal bleeding. 
3. Patients with clinically unhealthy cervix diagnosed by speculum 
examination like cervical erosion, Hypertrophy, growth etc. 
4. Patients with pap smears showing dysplasia. 
 
Exclusion criteria 
1. Women with age more than 60 years and less than 20 years. 
2. Pregnant women 
3. Women who have not had coitus. 
4. Women who underwent cauterization, cryotherapy or radiotherapy. 
5. Women who underwent total hysterectomy. 
 
  
50 patients from outpatient gynaec department and gynaec ward were 
randomly selected. A detailed history regarding the age, occupation, 
educational status, socioeconomic status, history of STD, OCP Usage, No. 
of partners, age at first intercourse, presenting complaints, menstrual history, 
marital history and obstetric history were recorded. It was followed by 
speculum examination and bimanual pelvic examination. Cervical biopsy 
taken from all the patients. 
 
Technique of punch biopsy of cervix 
1. Patient was placed in lithotomy position. 
2. The labia were separated and a sim's speculam was introduced into 
the vagina. 
3. The cervix was visualized. 
4. Punch biopsy was taken using biopsy forceps. 
 
Tray of cervical punch biopsy contains, 
1. Sim's speculum 
2. Cervical biopsy forceps 
3. 10% formalin 
 
Materials for AgNOR staining 
1. 5μ thin histopathological sections. 
2. 20% aquous silver nitrate solution. 
3. 2% gelatin. 
4. 1% formic acid. 
 
 
  
 The specimens were fixed in 10% formalin. After paraffin embedding, 
5μ thin sections were made and stained. Apart from the routine hematoxylin 
and Eosin stain, special stain for AgNOR staining was used. 
 
 Each of the samples then subjected to an argyrophilic staining for the 
nucleolar organizer region according to the modified colloidal silver 
technique of Crocker et al (Loc cit 1989). 
 
AgNOR Stain 
 
Method of preparing colloidal silver staining solution 
 It was prepared by mixing 2 volumes of 20% aquous silver nitrate 
solution (20g/dl) with one volume of 2% gelatin (2 g/dl) in 1% formic acid (1 
g/dl). 
 
Staining Procedure 
1. 5μ thin sections were cut from the routinely processed, formalin fixed 
tissue and were de-paraffinised and brought through graded alcohols. 
2. The slides were then immersed in distilled water for 10 minutes. 
3. The sections were then layered with silver nitrate gelatin formic acid 
solution. 
4. The slides were then incubated in a dark room for 40 minutes at room 
temperature. 
5. The slides were then washed in distilled water dehydrated, cleared 
and  mounted in D.P.X. mountant. 
 
  
AgNOR Score 
 The stained slides were viewed under oil immersion and intra nuclear 
silver dots are hand counted making use of light microscope. After counting 
atleast 100 cells, AgNOR score was calculated, i.e. Mean number of AgNOR 
dots per nucleus. The count was repeated by another person to minimize 
observer error. 
 
 Three main types of AgNOR configuration can be described in normal 
or neoplastic cells. They are shown in the Diagram 3 to 5. 
 
 In diagram 3, the NORs are fully aggregated to form a solitary, 
rounded argyrophil structure, often called an AgNOR but corresponding to 
the nucleolus. 
 
 Diagram 4 shows a nuclear pattern which is often seen in proliferating 
cells where NORs can be seen within the nucleolus. 
 
 Diagram 5 represents the distribution of small true AgNORs 
throughout the nucleoplasm as frequently observed in highly malignant cells 
Crocker et al (loc cit 1988). 
 
There are two approaches to count AgNORs 
 Firstly all silver stained structures could be counted, but when lying in 
groups each cluster (almost aggregated or partly disaggregated nucleoli) 
treated as one structure (Type 1 method). 
 
  
 Secondly, where AgNORs can be separately seen within a nucleolus, 
each AgNOR could be counted as a  unit, together with the smaller AgNORs 
seen outside the Nucleolus (Type 2 method). Type 2 method has been 
followed in our study. 
 
 It has been observed that Type 2 method of counting have higher 
AgNOR scores than Type 1 method of counting. 
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RESULTS AND ANALYSIS 
 
A. CHARACTERISTICS OF THE SELECTED CASES 
 
Table 1 : Age 
Cases Age group 
No. % 
20-29 5 10 
30-39 12 24 
40-49 16 32 
50 & above 17 34 
Total 50 100 
Mean 43.9 yrs 
S.D. 11.2 
 
 Among the 50 women studied, 10% were between 20-29 years; 24% 
were between 30-39 years, 32% were between 40-49 years and 34% were 
50 years and above. 
 
Table 2 : Education 
Cases Education 
No. % 
Illiterates 26 52 
Up to 10th Std. 17 34 
+1, +2, Degree 7 14 
 
 Among the 50 women studied, 52% were illiterates; 34% had primary 
/ high school education and 14% had higher education. 
  
Table 3 : S.E. Status 
Cases S.E. Status 
Income Rs. Per month No. % 
I < 1000 38 76 
II 1001-1500 7 14 
III 1500-2000 5 10 
IV > 2000 - - 
 
 Majority (76%) of women belonged to low income group, (< 1000 Rs. 
Per month). 
 
Table 4 : Parity 
Cases Parity 
No. % 
1 3 6 
2 18 36 
3 19 38 
4 & above 10 20 
Mean 2.7 
S.D. 0.9 
 
 Among the 50 women studied, 6% were para 1; 36% were para 2; 
38% were para 3 and 20% were para 4 and above; Majority were para 2 and 
above. 
 
  
Table 5 : Duration of marital  life 
 
Cases Duration of marital life 
No. % 
< 5 yrs 4 8 
5-10 yrs 14 28 
11-20 yrs 14 28 
> 20 yrs 18 36 
 
 
 Among the 50 women studied, 8% have < 5 years of marital life; 28% 
have 5-10 years of marital life; another 28% have 11-20 years of marital life 
and 36% have more than 20 years. Majority of women have sexual life of > 
20 years. 
 
Table 6 : Multiple Sex Partners 
 
Cases More than one 
partner No. % 
Yes 1 2 
No 49 98 
 
 
 Among the study group, 2% had contact with more than one partner. 
 
 
 
 
 
  
Table 7 : Contraception 
 
Cases Contraception 
No. % 
Barrier 2 4 
OCP 3 6 
IUCD 6 12 
Permanent 21 42 
Nil 18 36 
 
 Among the 50 women studied, 4% practiced barrier method, 6% were 
taking OCP; 12% of women had IUCD inserted; 42% were permanently 
sterilized and 36% of women did not practice any form of contraception; In 
our study group, majority of women were permanently sterilized. 
 
  
Table 8 : Complaints 
 
Cases Complaints 
No. % 
Bleeding 
Present 
i. Post coital bleeding 
ii. Post menopausal 
bleeding 
iii. Inter menstrual 
bleeding 
 
22* 
4 
13 
 
5 
 
44 
8 
26 
 
10 
White Discharge 
       Present 
 
 
31* 
 
 
62 
 
*Both bleeding & white discharge 3 6 
 
 
 The common complaints, the woman presented with were either white 
discharge or bleeding pv 62% presented with white discharge. 44% 
presented with bleeding, out of which 8% postcoital, 26% postmenopausal 
and 10% inter menstrual bleeding. 3 patients presented with both the 
complaints. 
 
 
 
 
  
Table 9 
Previous History of STD and Screening 
 
Cases  
No. % 
H/O STD 
a) Present 
b) Absent 
 
- 
50 
 
- 
100 
Previous screening  
a) Present 
b) Absent 
 
- 
50 
 
- 
100 
 
 Among the study group, none of them gave proper H/O STD in the 
past or previous screening. 
 
  
Table 10 
Clinical appearance of cervix by speculum examination 
 
Cases  
No. % 
I.  Erosion  
a) Present 
b) Absent 
 
25 
25 
 
50 
50 
II. Growth  
a) Present 
b) Absent 
 
19 
31 
 
38 
62 
III. Hypertrophy 
1. Present 
2. Absent 
 
4 
46 
 
8 
92 
IV Ulcer 
1. Present 
2. Absent 
 
2 
48 
 
4 
96 
 
When cervix was visualized using a speculum, the appearance were 
erosion in 50%, hypertrophy in 8% and growth in 38% and Ulcer in 4%. 
 
  
Table 11   
Histopathological examination 
 
 No. % 
Chronic cervicitis 21 42 
Metaplasia 1 2 
Mild dysplasia 4 8 
Severe dysplasia 4 8 
Well differentiated squamous cell carcinoma 4 8 
Moderately differentiated squamous cell carcinoma 14 28 
Adeno carcinoma 2 4 
 
 
 Among the studied 50 cases with abnormal symptoms, HPE showed 
chronic cervicitis in 42% of cases, mild dysplasia in 8%, severe dysplasia in 
8%, metaplasia in 2% , well differentiated squamous cell carcinoma in 8% of 
cases, moderately differentiated squamous cell carcinoma in 28% of cases 
and adeno carcinoma in 4% of cases. 
 
  
B. CHARACTERISTICS AND HPE FINDINGS 
1. Age and HPE Findings  
Table 12 
HPE Findings 
Chro. 
Cervicitis 
Metaplasia Mild 
dysplasia 
Severe 
dysplasia 
SCC. Well 
differentiated 
SCC.mod. 
differentiated 
Adeno 
carcinoma 
 
 
Characteristics 
No. % No. % No. % No. % No. % No. % No. % 
Age 
20 - 29 
30-39 
40-49 
50 & above 
Total 
 
2 
5 
10 
4 
21 
 
9.5 
23.8 
47.6 
19 
100 
 
- 
1 
- 
- 
1 
 
- 
100 
- 
- 
100 
 
1 
3 
- 
- 
4 
 
25 
75 
- 
- 
100 
 
1 
2 
- 
1 
4 
 
25 
50 
- 
25 
100 
 
- 
1 
1 
2 
4 
 
- 
25 
25 
50 
100 
 
1 
- 
5 
8 
14 
 
7.1 
- 
35.7 
57.1 
100 
 
- 
1 
1 
- 
2 
 
- 
50 
50 
- 
100 
Mean 
S.D. 
40.5 
7.7 
30.0 
- 
34.0 
6.9 
39.3 
14.3 
48.0 
14.7 
51.2 
10.5 
40.0 
10 
‘p’ 0.0001 
 
Chronic cervicitis was reported in the all age groups from 20 to 50 
years and above. 47.6% of patients (10/21) belonged to the age group 40 to 
49 years.  
 
Metaplasia was reported in 1 patient in the age group 30 to 39 years. 
 
Mild dysplasia was seen mostly in the age group 30 to 39 years. A 
few (25%) were in the age group 20 – 29 years. 
 
Severe dysplasia (75%) was mainly reported in the age group 20 – 39 
years. 
 
Well differentiated carcinoma was seen in the age group 30 to 50 
years and above. 
 
Moderately differentiated carcinoma was seen mainly (92.9%) above 
40 years. Only one patient below the age of 30 was reported to have 
moderately differentiated carcinoma. 
 
Only two patients were reported to have adenocarcinoma and fell in 
the 30 – 49 years age group. 
  
2. Education and HPE Findings. 
HPE Findings 
Chro. 
Cervicitis 
Metaplasia Mild 
dysplasia 
Severe 
dysplasia 
SCC. Well 
differentiated 
SCC.mod. 
differentiated 
Adeno 
carcinoma 
 
No. % No. % No. % No. % No. % No. % No. % 
Education 
Illiterates 
Upto 10th Std 
+1, +2, Degree 
 
10 
8 
3 
 
47.6 
38.1 
14.3 
 
- 
- 
1 
 
- 
- 
100 
 
1 
2 
1 
 
25 
50 
25 
 
2 
1 
1 
 
50 
25 
25 
 
2 
2 
- 
 
50 
50 
- 
 
10 
3 
1 
 
71.5 
21.4 
7.1 
 
1 
1 
- 
 
50 
50 
- 
  
There was not much significant difference between illiteracy and 
literacy in the distribution of benign and malignant lesions in our study.
  
3. Socioeconomic status and HPE Findings 
HPE Findings 
Chro. 
Cervicitis 
Metaplasia Mild 
dysplasia 
Severe 
dysplasia 
SCC. Well 
differentiated 
SCC.mod. 
differentiated 
Adeno 
carcinoma 
 
S.E. 
Group 
No. % No. % No. % No. % No. % No. % No. % 
 
I 
II 
III 
 
12 
5 
4 
 
57.1 
23.8 
19 
 
1 
- 
- 
 
100 
- 
- 
 
3 
1 
- 
 
75 
25 
- 
 
3 
1 
- 
 
75 
25 
- 
 
4 
- 
- 
 
100 
- 
- 
 
14 
- 
- 
 
100 
- 
- 
 
1 
- 
1 
 
50 
- 
50 
 
Chronic cervicitis, dysplasia and malignancy were more prevalent in 
the lower income group. 
  
4. Parity and HPE Findings 
 
HPE Findings 
Chro. 
Cervicitis 
Metaplasia Mild 
dysplasia 
Severe 
dysplasia 
SCC. Well 
differentiated 
SCC.mod. 
differentiated 
Adeno 
carcinoma 
 
No. % No. % No. % No. % No. % No. % No. % 
Parity 
1 
2 
3 
> 4 
 
1 
9 
7 
4 
 
4.8 
42.9 
33.3 
19 
 
- 
- 
1 
- 
 
- 
- 
100 
- 
 
- 
1 
3 
- 
 
- 
25 
75 
- 
 
- 
1 
2 
1 
 
- 
25 
50 
25 
 
- 
2 
1 
1 
 
- 
50 
25 
25 
 
1 
4 
5 
4 
 
7.1 
28.6 
35.7 
28.6 
 
1 
1 
- 
- 
 
50 
50 
- 
- 
 
Chronic cervicitis was more prevalent in multipara (42.9 + 33.3 + 19 = 
95.2%) than in primipara (4.8%). Similarly dysplasia were also more prevalent in 
multipara (25 + 50 = 75%) 
  
 
5. Duration of Marital Life and HPE findings 
HPE Findings 
Chro. 
Cervicitis 
Metaplasia Mild 
dysplasia 
Severe 
dysplasia 
SCC. Well 
differentiated 
SCC.mod. 
differentiated 
Adeno 
carcinoma 
 
No. % No. % No. % No. % No. % No. % No. % 
Duration of 
marital life 
< 5 yrs 
5-10 yrs 
11-20 yrs 
> 20 yrs 
 
 
2 
7 
6 
6 
 
 
9.5 
33.3 
28.6 
28.6 
 
 
- 
1 
- 
- 
 
 
- 
100 
- 
- 
 
 
- 
3 
- 
1 
 
 
- 
75 
- 
25 
 
 
1 
1 
1 
1 
 
 
25 
25 
25 
25 
 
 
- 
- 
2 
2 
 
 
- 
- 
50 
50 
 
 
1 
2 
5 
6 
 
 
7.1 
14.2 
35.7 
42.7 
 
 
- 
- 
- 
2 
 
 
- 
- 
- 
100 
 
 Sexual activity is associated with the changes in the cervix – 
inflammatory changes ie chronic cervicitis was seen in women who exposed 
to sexual activity for more than 5 years duration. 
 
 Similarly in those with dysplasia and invasive carcinoma, majority      
(75 – 93%) had a sexual life of more than 5 years duration.  
  
6. Multiple sex partners and HPE findings 
HPE Findings 
Chro. 
Cervicitis 
Metaplasia Mild 
dysplasia 
Severe 
dysplasia 
SCC. Well 
differentiated 
SCC.mod. 
differentiated 
Adeno 
carcinoma 
 
No. % No. % No. % No. % No. % No. % No. % 
Yes 
No 
1 
20 
4.8 
95.2 
- 
1 
- 
100 
- 
4 
- 
100 
- 
4 
- 
100 
- 
4 
- 
100 
- 
14 
- 
100 
- 
2 
- 
100 
  
Only 4.8% of patients with chronic cervicitis came out with the history of 
having multiple sex partners. Contradictorily such a history was not present 
in those patients with malignancy or dysplasia. 
   
7. Contraception and HPE findings 
HPE Findings 
Chro. 
Cervicitis 
Metaplasia Mild 
dysplasia 
Severe 
dysplasia 
SCC. Well 
differentiated 
SCC.mod. 
differentiated 
Adeno 
carcinoma 
 
No. % No. % No. % No. % No. % No. % No. % 
 
Barrier 
OCP 
IUCD 
Permanent 
Nil 
 
1 
2 
4 
8 
6 
 
4.8 
9.5 
19 
38.1 
28.6 
 
1 
- 
- 
- 
- 
 
100 
- 
- 
- 
- 
 
- 
- 
1 
2 
1 
 
- 
- 
25 
50 
25 
 
- 
- 
- 
2 
2 
 
- 
- 
- 
50 
50 
 
- 
- 
1 
2 
1 
 
- 
- 
25 
50 
25 
 
- 
1 
- 
6 
7 
 
- 
7.1 
- 
42.9 
50 
 
- 
- 
- 
1 
1 
 
- 
- 
- 
50 
50 
 
OCP use was not associated with dysplasia or Adenocarcinoma. Only 
9.5% of patients (2/21) with chronic cervicitis and 7.1% of patients (1/14) 
with moderately differentiated carcinoma gave the history of OCP usage. 
 
  
 
8. Complaints and HPE findings 
 
HPE Findings 
Chro. 
Cervicitis 
Metaplasia Mild 
dysplasia 
Severe 
dysplasia 
SCC. Well 
differentiated 
SCC.mod. 
differentiated 
Adeno 
carcinoma 
 
No. % No. % No. % No. % No. % No. % No. % 
Complaints  
Bleeding only  
Present 
 
- 
 
 
- 
 
 
- 
 
- 
 
 
- 
 
 
- 
 
 
1 
 
25 
 
 
4 
 
 
100 
 
 
12 
 
 
85.7 
 
 
2 
 
 
100 
 
White 
discharge 
only 
Present 
 
 
 
21 
 
 
 
100 
 
 
 
1 
 
 
 
100- 
 
 
4 
 
 
 
100 
 
 
 
2 
 
 
 
50 
 
 
 
- 
 
 
 
- 
 
 
 
- 
 
 
- 
 
 
 
- 
 
 
 
- 
 
Both bleeding 
and white 
discharge 
- - - - - - 1 25 - - 2 14.2 - - 
 
  In all the patients with chronic cervicitis and mild dysplasia the only 
complaint was white discharge pv. In all the patients with invasive carcinoma 
the main complaint was bleeding pv. 
 
In severe dysplasia 50% gave complaint of white discharge 25% gave 
the history of bleeding and 25% gave the history of both. 
  
9. Clinical appearance of cervix and HPE findings 
HPE Findings 
Chro. 
Cervicitis 
Metaplasia Mild 
dysplasia 
Severe 
dysplasia 
SCC. Well 
differentiated 
SCC.mod. 
differentiated 
Adeno 
carcinoma 
 
No. % No. % No. % No. % No. % No. % No. % 
Erosion 
Present 
Absent 
 
17 
4 
 
81 
19 
 
1 
- 
 
100 
- 
 
3 
1 
 
75 
25 
 
4 
- 
 
100 
- 
 
- 
4 
 
- 
100 
 
- 
14 
 
- 
100 
 
- 
2 
 
- 
100 
Growth 
Yes 
No 
 
- 
21 
 
- 
100 
 
- 
1 
 
- 
100 
 
1 
3 
 
25 
75 
 
- 
4 
 
- 
100 
 
4 
- 
 
100 
- 
 
12 
2 
 
85.7 
14.3 
 
2 
- 
 
100 
- 
Hypertrophy 
Yes 
No 
 
4 
17 
 
19 
81 
 
- 
1 
 
- 
100 
 
- 
4 
 
- 
100 
 
- 
4 
 
- 
100 
 
- 
4 
 
- 
100 
 
- 
14 
 
- 
100 
 
- 
2 
 
- 
100 
Ulcer 
Yes 
No 
 
- 
21 
 
- 
100 
 
- 
1 
 
- 
100 
 
- 
4 
 
- 
100 
 
- 
4 
 
- 
100 
 
- 
4 
 
- 
100 
 
2 
12 
 
14.3 
85.7 
 
- 
2 
 
- 
100 
 
In 81% of patients with chronic cervicitis (17/21), 75% of patients with 
mild dysplasia (3/4) and 100% of patients with metaplasia and severe 
dysplasia – speculum examination showed erosion cervix. In rest of the 
chronic cervicitis patients, the cervix appeared normal. 
 
 85.7% of invasive cancers (12/14) presented with a friable growth. 
14.3% of patients with invasive carcinoma (2/14) showed an ulcerative 
growth which bled on touch. 
  
C. RELATIONSHIP BETWEEN CHARACTERISTICS OF CASES AND 
AGNOR SCORES 
 
1. Age and AgNOR Score 
 
AgNOR Score Age group 
Mean S.D. 
20-29 3.6 2.6 
30-39 3.08 1.62 
40-49 4.06 1.91 
50 & above 5.41 2.06 
Total 4.24 2.1 
'p' 0.0233 (Significant) 
  
Among the various age groups, there exist statistically significant 
difference in AgNOR scores. As the age increases, the proliferative activity 
of cells also increases; it is expressed as increase in AgNOR counts. 
 
Table 2 : Education and AgNOR Score 
AgNOR Score Education 
Mean S.D. 
Illiterates 4.77 2.16 
Up to 10th Std. 3.82 1.91 
+1, +2, Degree 3.29 1.98 
'p' 0.16315 (Not Significant) 
 
 Educational status of the patients and the AgNOR score do not have 
any significant relationship. 
  
 
Table 3 : S.E. Status and AgNOR Score 
 
AgNOR Score S.E. Status 
Mean S.D. 
I < 1000 Rs. / month 4.58 2.16 
II 1001-1500 3.29 1.38 
III 1500-2000 3.0 1.73 
IV > 2000 - - 
'p' 0.1715 (Not Significant) 
  
S.E. Status does not have a statistically significant relationship with 
AgNOR score. 
 
Table 4 : Parity and AgNOR Score 
 
AgNOR Score Parity 
Mean S.D. 
1 4.67 2.52 
2 4.17 2.18 
3 4.05 2.15 
4 4.6 1.72 
'p' 0.5371 (Not Significant) 
  
Parity of the patient and the AgNOR score are not significantly 
related. 
 
  
 
Table 5 : Duration of marital  life and AgNOR Score 
 
AgNOR Score Duration of marital life
Mean S.D. 
< 5 yrs 3.75 2.22 
5-10 yrs 2.93 1.54 
11-20 yrs 4.64 2.21 
> 20 yrs 5.06 1.98 
'p' 0.0194 (Significant) 
  
 Patients with longer duration of married life (> 10 years) have 
higher AgNOR score than recently married patients and this difference is 
statistically significant.  
 
 Duration of marital life has important role in the development of 
dysplasia and carcinoma. As the duration increases the chance of 
developing dysplasia and carcinoma also increases. 
 
Table 6 : Multiple Sex Partners and AgNOR Score 
 
AgNOR Score More than one partner 
Mean S.D. 
Yes 3.0 - 
No 4.27 2.11 
'p' 0.6974 (Not Significant) 
  
Having multiple sex partners does not significantly affect AgNOR 
score. 
  
 
Table 7 : Contraception and AgNOR Score 
 
AgNOR Score Contraception 
Mean S.D. 
Barrier 3.0 - 
OCP 3.5 3.0 
IUCD 2.67 1.75 
Permanent 4.43 2.06 
Nil 4.78 1.93 
'p' 0.2197 (Not Significant) 
  
Contraception status of the patients is not significantly related to 
AgNOR score. 
 
Table 8 : Complaints and AgNOR Score 
 
AgNOR Score for cases 
Present Absent 
Complaints 
Mean S.D. Mean S.D. 
Bleeding 6.04 1.22 2.7 1.29 
White discharge 3.0 1.59 6.26 0.87 
  
Patients with bleeding have higher AgNOR score than those with 
white discharge, as the carcinoma presents with bleeding. 
 
 
  
 
Table 9 : Clinical appearance of cervix and AgNOR Score 
AgNOR Score for cases 
Present Absent 
Clinical appearance of 
cervix 
Mean S.D. Mean S.D. 
Erosion 2.92 1.5 5.56 1.76 
Growth 6.05 1.08 3.13 1.76 
  
Patients with Erosion cervix have lower AgNOR than those without 
Erosion, patients with Growth have higher AgNOR score than those without 
it. These differences are also statistically significant. 
 
  
Table 10 : HPE Findings and AgNOR Score 
 
AgNOR Score 
HPE Findings No. of 
patients 
Mean S.D. 
Chronic Cervicitis 21 2.48 1.12 
 Mild dysplasia  4 2.5 0.58 
Severe dysplasia  4 5.5 0.58 
 Metaplasia 1 2.0 - 
Sec. Well differentiated 4 6.0 0.82 
Sec. Moderately 
differentiated 
14 6.36 0.93 
Adeno carcinoma 2 6.5 0.71 
Total 50 4.24 2.1 
'p' 0.0001 (Significant) 
 
            The various HPE findings exhibit statistically significant difference in 
AgNOR values. Chronic cervicitis, metaplasia, and mild dysplasia cases 
have very low scores and the other cases have higher AgNOR scores. 
 
 The higher score was present in adeno carcinoma, followed by 
moderately differentiated and then well differentiated squamous cell 
carcinoma. 
 
  
 
 
 
 
 
DISCUSSION 
  
DISCUSSION 
 
 Cervical cancer is the second most frequent cancer worldwide, in 
women after breast cancer. However, invasive cancer of cervix is considered 
to be a preventable condition as it is associated with a preinvasive stage 
(CIN) making it amenable to screening and treatment. 
 
 A study was conducted in the Gynaecology out patient department of 
GRH between the period May 2005 to May 2006. 50 Women with abnormal 
symptoms of white discharge and bleeding were screened for the presence 
of cervical pathology. A detailed history was elicited and a thorough clinical 
examination was done. Cervical biopsy was taken in all the 50 patients and 
the sections were stained with conventional H&E stain to study the HPE and 
with silver stain to study the AgNOR scores. AgNOR score was correlated 
with HPE report. 
 
 Regarding age distribution, high incidence of chronic cervicitis (70%) 
was seen in the age group 30-49. Shalini et al showed that 32 year is the 
mean age of patients with benign pathology in her study.  
 
 Dysplasia was found to be more common between 20-39 years. 
Kushtagi and Fernandes in their study showed the prevalence of dysplasia 
was higher in women over 30 years. Vaidya showed in his study that CIN 
was more prevalent in the age group of > 35 years. 
 
 Squamous cell carcinoma was found to be more common between 
40-60 years. Shalini et al showed 25% of well differentiated and 35% of 
  
moderately differentiated carcinomas in the age group 40-49; 50% of well 
differentiated and 57% of moderately differentiated carcinoma were in age 
group > 50. The mean age of patient with cancer cervix was 41. 
 
 Regarding educational status, abnormal cervical lesions like chronic 
cervicitis, dysplasia and malignancies were more common among illiterates 
> 50% of cancers and > 25% of dysplasias were seen in illiterates. This was 
attributed to lack of awareness of symptoms and failure to seek medical 
care. 
 
 Socio economic status had always been playing an epidemiological 
role in genesis of dysplasia. In our study, chronic cervicitis, dysplasia and 
invasive cancers were more common in low income group, 75% of severe 
dysplasia and 100% invasive cancers were seen in low income group. 
 
 Vaidya had showed that low socio economic status had a definite role 
in the development of dyskaryosis. In his study 80% of CIN I and 50% of CIN 
II were from low income group. Poor personal hygiene, poor living 
conditions, unstable marriages and early age at first intercourse are factors 
associated with both low socio economic conditions and cervical cancer. 
 
 Regarding parity, our study showed increased incidence of dysplasia 
and invasive carcinomas among multiparous women. In patients with severe 
dysplasia 25% were P2, 50% were P3, 25% were P4 & above. Among 
invasive cancer patients, 50% were P2, 35% were P3 and 30% were P4 and 
more. 
 
  
 Similar study by Shalini et al showed the mean parity was 4.2 in 
patients with invasive cancer. Kushtagi and Fernandez showed the 
prevalence of CIN was significantly higher in parity of more than 2. Vaidhya 
also showed more positive cases of CIN with parity more than 4. This might 
be attributed to hormonal and nutritional changes that occur in pregnancy, 
immunosuppression during pregnancy and cervical trauma during vaginal 
delivery (Becker et al and Adadevoh et al). 
 
 Duration of marital life that is duration of exposure to sexual 
intercourse has a distinct role in genesis of cervical dysplasia and 
carcinoma. In our study, incidence of dysplasia was 25-75% in women with 
marital life of 5-20 years. Incidence of squamous cell carcinoma was about 
50% in patients with marital life more than 20 years. Kushtagi et al had 
demonstrated the severity of underlying CIN increased with increase in the 
duration of marital life and hence the increase in the duration of sexual 
intercourse. 
 
 Increasing number of sexual partners had the effect on increasing the 
risk of developing dysplasia and invasive disease. In our study only 2% of 
women revealed the history of more than 1 partner, out of which 4.8% had 
chronic cervicitis. 
 
 The relationship between oral contraceptives and development of CIN 
had been investigated by IARC – International Agency for Research in 
Cancer and they concluded that the use of OCP increased the risk of CIN 
upto 4 fold after 5 or more years, among the HPV DNA positive women. In 
  
our study 9.5% of patients with chronic cervicitis used OCP. But non of those 
with invasive cancer or dysplasia used OCPs 
 
 Chronic cervicitis was more common in patients using IUCD and OCP 
apart from permanent sterilization. Among the chronic cervicitis patients, 
28.6% were not using any methods. 
 
 25% of patients with mild dysplasia used IUCD 50% of mild and 
severe dysplasia patients were permanently sterilized; 25% of mild and 50% 
severe dysplasia patients were not using any methods. 50% of patients with 
squamous cell carcinoma were permanently sterilized or non users of 
contraceptive methods. 
 
 Prospective studies by Sten et al in los angeles suggested an 
increased risk of progression of cervical dysplasia among the users of 
hormonal contraceptives. Vaidya et al in their study showed 40% risk of CIN 
I in women who had depot provera injection. According to Duggan, OCP 
produce progression to CIN, by regulating oncogenic sequence of HPV. 
Since our study sample was small we could not prove it. 
 
 Among the complaints, white discharge was present in majority of 
women with chronic cervicitis, dysplasia and metaplasia. Excessive vaginal 
discharge playing a role in contributing to the development of CIN was also 
proved to be a risk factor in the study conducted by Vaidya et al. In their 
study 24% had vaginal discharge. 
 
  
 Post coital bleeding was found in 50% of patients with severe 
dysplasia. Shalini R Amita S, in their study, showed the relationship of post 
coital bleeding and CIN. In their study, among the women who had post 
coital bleeding, 85.5% had benign findings; 5-6% had HPV and CIN I; 3.6% 
had CIN II and III and 5.5% had invasive cancer. There was no correlation 
between the duration of bleeding and pathology. 
 
 Regarding the clinical appearance of cervix, the most common finding 
was erosion in patients with chronic cervicitis (81%) and mild dysplasia 75%. 
In all patients with severe dysplasia, cervix was badly eroded and bled on 
touch. Patients with invasive squamous cell and adeno carcinomas 
presented with a friable growth or ulcer. 
 
 The expression AgNOR designates the silver stained NOR proteins. 
The AgNOR technique is remarkably specific for detection of NORs by virtue 
of silver binding to a wide array of NOR associated proteins (NOR Aps) 
 
 The AgNOR technique stains the NORs as black dots in the nucleus. 
 
 The number and size of the NOR dots in malignant cells is 
significantly different from that in normal or benign cells and reflects the 
current phase of transcription of cells. Marked cellular atypia is present in 
repair and regeneration of squamous and columnar epithelia. Cells from 
epithelial repair have enlarged nuclei which vary in size and shape. AgNOR 
technique provides an index of cell proliferation. The number, shape and 
distribution of AgNOR dots counted in the cell gives information not only 
about the morphology but also about the behaviour of the cell. There is 
  
progressive increase in the mean AgNOR count in cells with squamous 
metaplasia and in cells undergoing repair upto various grades of CIN 
demonstrating ongoing proliferation. In the present study it was observed 
that the mean AgNOR count per cell increases from metaplasia to 
carcinoma. 
 
 In our study there was no significant difference in AgNOR counts 
between squamous metaplasia and chronic cervicitis. The mean number of 
AgNORs per nucleus was significantly higher in dysplasia (mild – 2.5+0.58, 
severe – 5.5 + 0.58 and malignant lesions (squamous cell well diff. – 6+0.82, 
mod. Diff. 6.3+0.93, adeno carcinoma – 6.5+0.71) as compared to 
metaplasia – 2 and chronic cervicitis 2.5+1.15. All carcinomas and severe 
dysplasia had significantly higher AgNOR counts per nucleus compared to 
mild dysplasia. NOR counts were significantly higher in adeno carcinoma 
when compared to squamous cell carcinoma. Statistical analysis revealed 
significant difference between mean AgNOR counts of chronic cervicitis and 
dysplasia; mild dysplasia and severe dysplasia, severe dysplasia and 
invasive carcinoma, squamous cell carcinoma and adeno carcinoma. 
 
 Overall the mean AgNOR counts for carcinoma cervix were increased 
from chronic cervicitis and dysplasia. 
 
 The differences in AgNOR count between mild dysplasia and severe 
dysplasia were statistically significant.  
 
 Eagan et al observed that mean AgNOR count increased steadily 
whereas the mean size of AgNORs decreased from CIN I to CIN II. Cardillo 
  
studied AgNOR counts in cervical smears of squamous metaplasia and 
cervical intra epithelial neoplasia. The smears previously stained with 
papanicolaou technique were destained and restained with AgNOR silver. 
He found statistically significant difference (p < 0.05) in AgNOR counts in 
squamous metaplasia and various grades of CIN. 
 
 An Indian study done by Prathiba and Kuruvilla (1995) on the role of 
AgNOR in diagnosis of premalignant and malignant lesions of the cervix, 
showed that mean AgNOR count progressively increased from normal to 
CIN I, CIN II, CIN III and invasive carcinoma. The difference between counts 
in CIN I and CIN II and invasive carcinoma was statistically significant. 
 
 However Rowland in a study on nucleolar organizing regions in 
cervical epithelial neoplasia, did not find any significant differences in 
AgNOR count / in squamous epithelium of normal cervix; CIN I and CIN II 
but there was a small but significant increase in CIN III group; the table 
shows mean AgNOR counts in various grades in different studies. 
 
  
Comparative studies 
Studies CC Metaplasia CIN I, II 
(mild 
Dysplasia) 
CIN III 
(Severe) 
Well Scc Poorly / 
mod. 
Diff. Scc 
Adeno 
Ca. 
Prathiba 
Karuvilla, 
1995 
- - 1.8 3 4.3 Could not 
be 
counted 
- 
Rowlands 
1998 
- - 2.2 2.8 - - - 
Crocker et 
al, 1990 
- - 2.9 4.7 - - - 
Iyomita 
Agarwal, IK 
Gupta, 1997 
1.56+.42 1.74+.32 3.5+0.04 5.1 5.27+.65 5.37 6.4 
Rajnikaushik 
study, 1999 
2.3 - 3.8 5.1 - 6.4 6.7 
Present 
study 
2.5+1.15 2 2.5+0.58 5.5+0.58 6+0.82 6.36+0.93 6.5+0.71 
 
 
 Crocker et al in 1990 also showed statistically significant difference in 
AgNOR counts between CIN I, CIN II and CIN III. 
 
 In Jyomita Agarwal, JK Gupta study (1997) AgNORs were counted in 
biopsies from 202 cases of various lesions and cervix. The mean number of 
AgNORs per nucleus was significantly higher in CIN (4.05+0.04) and 
Malignancy (5.50+0.65) as compared to squamous metaplasia (1.74+0.32) 
and chronic cervicitis (1.54+0.42). Adeno carcinomas had higher AgNOR 
counts as compared to other carcinomas. It concluded that the estimation of 
  
AgNORs can be helpful in distinguishing benign lesions from CIN and 
malignancy of the cervix. 
 
 In Rajni Kaushik, study, 1995 the mean AgNOR counts in cervical 
epithelium showed a progressive and statistically significant increase from 
normal to chronic cervicitis to CIN I, II and III (p < 0.001). Scores in 
carcinoma also exceeded that of CIN (p < 0.05). It concluded that this can 
prove to be a useful adjunct to routine histopathology to evaluate cervical 
lesions. 
 
 Although variations in different studies, the difference is statistically 
significant in various grades of CIN in all studies except in the study reported 
by Rowlands. 
 
 In our study it was also noted that the size of AgNOR dots decreased 
with increase in AgNOR count. This is in accordance with the study reported 
by Eagan who noted an inverse relationship between AgNOR numbers and 
sizes, and proved that severe dysplasia could be distinguished from mild 
dysplasia on the basis of AgNOR size. 
  
 
 
 
 
 
 
SUMMARY 
  
SUMMARY 
 
The study was conducted in the Department of obstetrics and 
Gynaecology between the period May 2005 to May 2006. 50 women with 
abnormal symptoms were screened for the presence of cervical pathology. 
Ectocervical biopsy was taken in all the patients. Tissue sections were 
stained with H&E stain for histopathology and with silver stain for AgNOR 
counts. AgNOR score was correlated with HPE report.  
 
71.4% (15/21) of chronic cervicitis, 50% (2/4) of well differentiated 
carcinoma, 35.7% (5/14) of moderately differentiated squamous cell 
carcinoma and all (100%) adenocarcinoma were reported in the age group 
30-49 yrs. All mild dysplasia (100%) and 75% (3/4) of severe dysplasia were 
found in the age group 20-39 yrs. 
 
Distribution of cervical lesions was not affected by the educational 
status.  
 
In addition to 80.9% of chronic cervicitis, all dysplasia and Malignancy 
were seen in low income group (100%). 
 
Chronic cervicitis (95%) and dysplasia (100%) were more commonly 
seen in Multipara than in Primipara. 
 
90% of chronic cervicitis, 100% of dysplasia and 92.9% invasive 
carcinoma were seen in patients with more than 5yrs of sexual life. 
 
  
Sexual promiscuity was present in only 4.8% (1/21) of patients with 
chronic cervicitis. 
 
Adeno carcinoma and dysplasia were not associated with OCP 
usage. Only 9.5% (2/21) of patients with chronic cervicitis and 7.1% (1/14) of 
patients with moderately differentiated squamous cell carcinoma used OCP. 
 
In all the patients with chronic cervicitis and mild dysplasia, the only 
complaint was white discharge pv. In invasive carcinoma (85-100%) the 
main complaint was bleeding pv. 50% of severe dysplasia were presented 
with white discharge and 25% were with bleeding pv. The remaining 
presented with both. 
 
81% (17/21) of patients with chronic cervicitis, 75% (3/4) of patients 
with mild dysplasia and 100% of patients with metaplasia and severe 
dysplasia showed erosion on speculum examination. 
 
85.7% (12/24) of Invasive carcinoma presented with friable growth. 
Ulcerative growth was seen in 14.3% (2/14) of patients with invasive 
carcinoma. 
 
As the age increases, AgNOR score also increases. 
 
Educational status, socio economic status and parity of the patients 
are not significantly related to AgNOR scores. 
 
  
Patients with long marital life (> 10years) have higher AgNOR score 
than recently married. 
 
Sexual promiscuity and contraception are not significantly related to 
AgNOR score. 
 
Patients with bleeding have higher AgNOR score (6.04) than those 
with white discharge (3). 
 
Patients with growth have higher AgNOR score (6.05) than those with 
erosion (2.92). 
 
Chronic cervicitis, metaplasia and mild dysplasia cases have low 
scores.  
 
The higher score was seen in adenocarcinoma (6.5 + 0.71) followed 
by moderately differentiated (6.36 + 0.93) and then well differentiated (6 + 
0.82) squamous cell carcinoma. 
 
  
 
 
  
  
 
 
 
 
 
 
CONCLUSION 
  
CONCLUSION 
 
 Earlier diagnosis of cervical dysplasia in adult women is a desirable 
goal. Cervical dysplasia lesions and early invasive cancers should be 
diagnosed in an earlier stage for instituting appropriate management. 
 
 Invasive cancer of cervix is considered to be preventable, since it is 
associated with a long preinvasive stage (CIN), making it amenable to 
screening and treatment. 
 
1. In the present study there is a significant difference in AgNOR counts 
between carcinoma cervix, dysplasia and chronic cervicitis. The mean 
AgNOR counts in cervical epithelium showed a progressive and statistically 
significant increase from chronic cervicitis, dysplasia, squamous cell 
carcinoma and adeno carcinoma. These findings strongly support the view 
that the proliferative activity of the lesion increases as the malignant potential 
of a lesion increases. Hence AgNOR scoring can be used as a reliable 
indicator of cell proliferation, in turn malignant potential of a lesion. 
 
2. AgNOR counts can be useful in differentiating doubtful cases of CIN. It is 
easy to perform, does not require an elaborate set up and is fairly 
economical which can be performed routinely in a histopathological 
laboratory. Another advantage of AgNOR counts lies in retrospective study. 
The samples can be destained and restained, when unstained slides are 
unavailable and also in doubtful cases whose corresponding histologic 
specimens are not available. It also has prognostic significance, it has been 
  
noted that CIN lesions with low AgNOR counts are more likely to regress in 
comparison to CIN lesions with high AgNOR counts. 
 
3. The findings in this study indicate that AgNOR technique can be used as 
an adjunct to routine histopathological examination of lesions of the cervix 
especially in dysplasia. Although more studies are necessary, our 
preliminary study indicates the potential diagnostic importance of AgNOR 
counts in cervical cancer and other cervical lesions. 
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PROFORMA 
  
PROFORMA 
Serial No. :     Name          : 
IP/ OP No. :     Age             : 
Income  :     Education    : 
I. Complaints 
1. Bleeding PV 
Post coital bleeding 
Continuous  / Intermittent 
Intermenstrual 
Post menopausal 
Associated pain 
2. Vaginal Discharge 
Duration 
Quantity 
Colour 
Foul smell 
Pruritis 
3. Lower abdominal pain  4. Urinary symptoms 
5. Bowel symptoms   6. Loss of weight 
7. Loss of appetite 
 
II. Personal History 
 Diet 
 Hygiene 
III. Menstrual History 
 Age at menarche 
 Cycles 
 LMP 
 Age at menopause 
 
 
 
  
IV. Married since 
V. Sexual promiscuity 
 Multiple sexual partners  
 History of STD 
• Husband 
• Wife 
VI. Obstetrical History 
 P L A 
 LCB 
 Contraception   
Barrier 
• OCP 
• IUCD 
• Permanent  
• Nil 
VII. General  Examination 
 Built     Thyroid 
 Anaemia    Breast 
 Pedal edema    BP 
 Lymphadenopathy   PR 
 CVS     RS 
VIII. Per abdomen 
IX. Local examination of Genitalia 
 Normal 
 Abnormal 
X. Speculum Examination 
 Cervix 
 Vagina 
XI. Per vaginal examination 
XII. P/R 
XIII. Biopsy 
XIV. AgNOR count 
 
  
 
 
Contraception 
 
2
3
6
21
18
0
5
10
15
20
25
Cases
Barrier OCP IUCD Permanent Nil
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
S.E. Status and AgNOR Score 
 
4.58
3.29
3
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
AgNOR Score
I < 1000 Rs. / month II 1001-1500 III 1500-2000 IV > 2000
 
 
Parity and AgNOR Score 
 
4.67
4.17
4.05
4.6
3.7
3.8
3.9
4
4.1
4.2
4.3
4.4
4.5
4.6
4.7
4.8
AgNOR Score
1 2 3 4
 
  
Duration of marital  life and AgNOR Score 
 
3.75
2.93
4.64
5.06
0
1
2
3
4
5
6
AgNOR Score
< 5 yrs 5-10 yrs 11-20 yrs > 20 yrs
 
 
Multiple sex partner and AgNOR Score 
 
3
4.27
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
AgNOR Score
Yes No
 
 
 
 
 
  
Contraception and AgNOR Score 
3
3.5
2.67
4.43
4.78
0
1
2
3
4
5
6
AgNOR Score
Barrier OCP IUCD Permanent Nil
 
 
 
Complaints and AgNOR Score 
 
6.04
2.7
3
6.26
0
1
2
3
4
5
6
7
8
9
10
Bleeding White discharge
Present Absent
 
  
Clinical appearance of cervix and AgNOR Score 
 
2.92
6.05
5.56
3.13
0
1
2
3
4
5
6
7
S.E Erosion Growth
Present Absent
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Diagram 1
Continuously dividing
Cells (labile)
G2
G0
G1
Permanent 
non dividing cells
Mitosis
S
CELL CYCLE
 
 
  
Diagram 2
 
 
 
 
 
 
 
 
 
 
 
  
 TWO RESTING CELLS SHOWING ONE OR TWO NUCLEOLI
 A TUMOUR CELL SHOWING AgNORs WITHIN THE NUCLEOLI
A MALIGNANT CELL SHOWING AgNORs SEEN LYING FREE IN THE NUCLEUS
Nuclear membrane
Nucleoli
Nucleoli
Nucleoli
Nuclear Membrane
Diagram 3
Diagram 4 
Diagram 5 
 
 
 
  
MILD DYSPLASIA
SEVERE  DYSPLASIA
 
 
 
 
 
  
SQUAMOUS CELL CARCINOMA
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
MATERIALS FOR AgNOR STAINING
CERVICAL BIOPSY TRAY
 
 
 
  
 
CHRONIC CERVICITIS WITH AgNOR SCORE 3
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
MILD DYSPLASIA WITH AgNOR SCORE 3 ADENOCARCINOMA WITH AgNOR SCORE 6SEVERE  DYSPLASIA WITH AgNOR SCORE 4
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
SQUAMOUS CELL CARCINOMA WITH AgNORE SCORE 5
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
MASTER CHART 
 
Speculum 
Examination OP No Age Education 
S.E.Status 
(Income 
per 
month) 
Parity 
Duration 
of m.life(in 
yrs) 
Multiple 
partners 
Contrac
eption Bleeding
White 
Discharge
H/o 
STD 
Prev.
scr. 
Erosion Growth
HPE 
89054 42 Nil 1001-1500 2 >20 Nil Perm. Nil Yes Nil Nil Yes Nil Ch. cer.
07524 28 <10 std 1001-1500 1 5-10 Nil IUCD Nil Yes Nil Nil Yes Nil Ch. cer.
06257 
58 Nil <1000 4 >20 Nil Nil PMB Nil Yes Nil Nil Yes 
SCC 
mod.diff
07567 
60 Nil <1000 2 11-20 Nil Nil PMB Nil Nil Nil Nil Yes 
SCC 
mod.diff
0306 38 <10 std <1000 3 5-10 Nil Perm. Nil Yes Nil Nil Yes Nil Mild dys
07715 
54 Nil <1000 4 >20 Nil Perm. PMB Nil Nil Nil Nil Yes 
SCC 
mod.diff
07813 
60 Nil <1000 3 >20 Nil Perm. PMB Nil Nil Nil Nil Yes 
SCC 
mod.diff
05066 45 <10 std 1001-1500 2 11-20 Nil Perm. Nil Yes Nil Nil Nil Nil Ch. cer.
07977 
40 <10 std <1000 3 11-20 Nil Perm. PC Nil Nil Nil Nil Nil 
SCC 
mod.diff
05344 
60 Nil <1000 4 11-20 Nil Nil PMB Nil Nil Nil Nil Yes 
SCC 
mod.diff
145 
60 Nil <1000 1 <5 Nil Nil PMB Nil Nil Nil Nil Yes 
SCC 
mod.diff
9714 45 <10 std 1500-2000 2 >20 Nil Nil PMB Nil Nil Nil Nil Yes Ade.car
90241 45 Nil <1000 4 11-20 Nil Perm. Nil Yes Nil Nil Nil Nil Ch. cer.
05248 
60 Nil <1000 5 >20 Nil OCP PMB Nil Yes Nil Nil Nil 
SCC 
mod.diff
08109 40 <10 std <1000 3 5-10 Nil Nil Nil Yes Nil Nil Nil Nil Ch. cer.
09385 36 Nil 1500-2000 3 11-20 Nil IUCD Nil Yes Nil Nil Yes Nil Ch. cer.
02571 45 <10 std <1000 3 11-20 Nil Nil Nil Yes Nil Nil Nil Nil Ch. cer.
07445 
60 Nil <1000 2 >20 Nil Nil PMB Yes Nil Nil Nil Yes 
SCC 
mod.diff
09340 
40 Nil <1000 2 5-10 Nil Perm. IMB Nil Nil Nil Nil Yes 
SCC 
mod.diff
08456 
45 <10 std <1000 2 >20 Nil Perm. IMB Nil Nil Nil Nil Yes 
SCC 
mod.diff
05457 30 <10 std 1001-1500 2 5-10 Nil OCP Nil Yes Nil Nil Yes Nil Ch. cer.
09098 35 Nil <1000 1 >20 Nil Perm. PMB Nil Yes Nil Nil Yes Ade.car
09146 32 >10 std 1001-1500 2 <5 Nil Barrier Nil Yes Nil Nil Yes Nil Ch. cer.
4322 
45 <10 std <1000 3 11-20 Nil Nil IMB Nil Nil Nil Nil Yes 
SCC 
mod.diff
2832 52 Nil <1000 2 11-20 Nil Perm. Nil Yes Nil Nil Yes Nil Ch. cer.
6217 
27 >10 std <1000 3 5-10 Nil Nil PC Yes Nil Nil Nil Yes 
SCC 
mod.diff
5938 50 <10 std <1000 4 >20 Nil Perm. Nil Yes Nil Nil Yes Nil Ch. cer.
24455 31 <10 std 1500-2000 2 5-10 Nil IUCD Nil Yes Nil Nil Yes Nil Ch. cer.
24346 40 Nil <1000 3 >20 Yes Nil Nil Yes Nil Nil Yes Nil Ch. cer.
7867 42 <10 std <1000 3 11-20 Nil Nil IMB Nil Yes Nil Nil Yes SCC.well.d
25471 41 >10 std <1000 3 5-10 Nil Perm. Nil Yes Nil Nil Yes Nil Ch. cer.
24176 46 Nil 1500-2000 2 >20 Nil Nil Nil Yes Nil Nil Yes Nil Ch. cer.
  
Speculum 
Examination OP No Age Education 
S.E.Status 
(Income 
per 
month) 
Parity 
Duration 
of m.life(in 
yrs) 
Multiple 
partners 
Contrac
eption Bleeding
White 
Discharge
H/o 
STD 
Prev.
scr. 
Erosion Growth
HPE 
8857 35 <10 std <1000 3 5-10 Nil Nil Nil Yes Yes Nil Yes Nil Sev. dys
2689 28 >10 std <1000 2 <5 Nil IUCD Nil Yes Nil Nil Yes Nil Ch. cer.
22896 50 <10 std <1000 4 >20 Nil Perm. Nil Yes Nil Nil Yes Nil Ch. cer.
25492 
48 Nil <1000 3 11-20 Nil Perm. IMB Nil Nil Nil Nil Yes 
SCC 
mod.diff
0518 
30 <10 std <1000 2 11-20 Nil IUCD PC Nil Nil Nil Nil Yes 
SCC 
Well.diff
26441 36 Nil <1000 3 5-10 Nil OCP Nil Yes Nil Nil Yes Nil Ch. cer.
1055 
60 Nil <1000 4 >20 Nil Perm. PMB Nil Nil Nil Nil Yes 
SCC 
Well.diff
6868 
60 Nil <1000 2 >20 Nil Perm. PMB Nil Nil Nil Nil Yes 
SCC 
Well.diff
6926 40 Nil 1500-2000 2 5-10 Nil Perm. Nil Yes Nil Nil Yes Nil Ch. cer.
4190 24 >10 std 1001-1500 2 5-10 Nil IUCD Nil Yes 2 2 Nil Yes Mild dys
4579 30 >10 std <1000 3 5-10 Nil Barrier Nil Yes 2 2 Yes Nil Metapla
4711 35 Nil <1000 3 11-20 Nil Perm. PC Nil 2 2 Yes Nil Sev. dys
23141 35 <10 std <1000 3 5-10 Nil Nil Nil Yes 2 2 Yes Nil Mild dys
4675 27 >10 std 1001-1500 2 <5 Nil Nil Nil Yes 2 2 Yes Nil Sev. dys
38254 39 Nil <1000 3 >20 Nil Perm. Nil Yes 2 2 Yes Nil Mild dys
32652 53 Nil <1000 4 >20 Nil Nil Nil Yes 2 2 Yes Nil Ch. cer.
32611 40 Nil <1000 3 11-20 Nil Nil Nil Yes 2 2 Yes Nil Ch. cer.
5803 60 Nil <1000 4 >20 Nil Perm. PMB Yes 2 2 Yes Nil Sev. dys
 
ABBREVIATIONS 
 
S.E. Status -  Socio Economic Status  OCP - Oral contraceptive pill 
 IUCD - Intra uterine contraceptive device  
Perm. – Permanent    PMB – Post menopausal Bleeding
 PC – Post coital bleeding 
IMB – Inter menstrual bleeding  Mild dys. – Mild dysplasia 
 Sev. dys. – Severe dysplasia 
Meta pla. – Metaplasia   Ch. Cer. – Chronic cervicitis 
 Ade.car. – Adeno carcinoma 
SCC Well diff. – Squamous cell carcinoma well differentiated  
SCC Mod. diff. – Squamous cell carcinoma moderately differentiated 
 
 
 
